Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Placenta accreta and the risk of adverse maternal and neonatal outcomes

Abstract

Objective: Placenta accreta is an increasingly prevalent and potentially dangerous complication of pregnancy. Although most studies on the subject have addressed the risk factors for the development of this condition, evidence on maternal and neonatal outcomes for these pregnancies is scarce. The objective of the present study is to compile current evidence with regard to risk factors as well as adverse outcomes associated with placenta accreta. Methods: We conducted a complete literature review using PubMed, MEDLINE, Cochrane Database Reviews, UptoDate, DocGuide, as well as Google scholar and textbook literature for all articles on placenta accreta, and any one of the following keywords: “risk factors”, “maternal outcomes”, “neonatal outcomes”, “morbidity”, and “mortality”. Individual case reports were excluded. Results: We reviewed 34 studies conducted between 1977 and 2012. A total number of 508,617 deliveries were studied, with 865 cases of confirmed placenta accreta (average pooled incidence=1/588). The development of placenta accreta appears to be most strongly predicted by a history of cesarean section, low-lying placenta/previa, in vitro fertilization pregnancy, as well as elevated second-trimester levels of α-fetoprotein and β-human chorionic gonadotropin. The most significant maternal outcomes include the need for postpartum transfusion due to hemorrhage and peripartum hysterectomy. Maternal mortality remains rare but significantly higher than among matched, postpartum controls. Important neonatal outcomes include preterm birth, low birth weight, small for gestational age, and reduced 5-min Apgar scores. Whether the need for neonatal intensive care unit admission and steroid administration is iatrogenic and whether an increased risk of perinatal mortality is a clinically significant and independent outcome remain controversial. Conclusion: Although there is a significant shortage of studies on the subject, it appears that placenta accreta is associated with adverse maternal and neonatal outcomes, some of which may be life threatening. Prenatal diagnosis and adequate planning, particularly in high-risk populations, may be indicated for the reduction of these adverse outcomes.

Overview

Integrity signals

Registry

Crossref · 10.1515/jpm-2012-0219

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Cited by

See all 133

Metadata

Authors
Balayla, J., & Bondarenko, H. D.
Affiliations
Université de Montréal (CA)
Corresponding author
Balayla, Jacques
Venue
jpme
Published
2012-12-15
Volume
41
Issue
2
Pages
141-149
ISSN
  • 0300-5577 (ISSN-L)
  • 1619-3997
OpenAlex
W2004529751
Cited by
128
References
37
Citations by year
2026: 3 · 2025: 7 · 2024: 10 · 2023: 16 · 2022: 9 · 2021: 13 · 2020: 14 · 2019: 10 · 2018: 16 · 2017: 11 · 2016: 5 · 2015: 4 · 2014: 3 · 2013: 5
FWCI
3.35
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Perinatal Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Maternal and fetal healthcare
  • Health Sciences › Medicine › Hematology › Blood transfusion and management
  • Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
Keywords
placenta accreta, placenta accreta spectrum, risk factors, maternal outcomes, neonatal outcomes, cesarean section, low-lying placenta, in vitro fertilization, alpha-fetoprotein, beta-hCG, postpartum hemorrhage, hysterectomy, maternal mortality, preterm birth, low birth weight, Apgar score, perinatal mortality, prenatal diagnosis
MeSH terms
Cesarean Section, Female, Postpartum Hemorrhage, Humans, Hysterectomy, Infant, Newborn, Placenta Accreta, Placenta Previa, Pregnancy, Pregnancy Outcome, Prenatal Diagnosis, Risk Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.